Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?

Body composition Diet Fat mass Lean mass Obesity Physical exercise Sarcopenia

Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
31 Aug 2024
Historique:
received: 11 07 2024
revised: 28 08 2024
accepted: 29 08 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 12 9 2024
Statut: aheadofprint

Résumé

The impact of dietary counseling on body composition in early breast cancer patients (EBC) treated with aromatase inhibitors (AIs) is uncertain. The aim of this study was to assess the effects of a diet counseling program on weight, BMI, total and regional body composition in patients treated with AIs. This observational study involved 194 EBC patients, of which 97 attended a 6-month personalized counseling program, based on Mediterranean diet principles (cohort A) and 97 did not (cohort B). Dual-energy X-ray absorptiometry (DXA) scan was used to measure the total and regional fat and lean body mass, before (baseline) and after at least 18 months of AI-therapy. Weight and BMI increased significantly, on the average, in cohort B, but not in cohort A. In the cohorts A and B, fat mass increased by 10 % and 7.7 % respectively, while lean mass decreased by 3.3 % and 2.6 % from before to after AI therapy, without statistically significant differences between them using the Mann-Whitney test. The changes in body composition were greater in premenopausal than in postmenopausal women at cancer diagnosis. The proportion of patients with sarcopenia, obesity and sarcopenic obesity increased from before to after AI therapy, similarly in both cohorts. Patients treated with AIs reported an increase in fat mass and a decrease in lean mass, and consequently an increase in sarcopenia and obesity, regardless of the participation in a dietary counseling program. A combined dietary counseling and physical exercise program may be necessary for preventing these unfavourable changes in these patients.

Identifiants

pubmed: 39265313
pii: S0960-9776(24)00125-5
doi: 10.1016/j.breast.2024.103794
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103794

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rebecca Pedersini (R)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy; SSVD Breast Unit, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Greta Schivardi (G)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Marta Laganà (M)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy. Electronic address: martagana@gmail.com.

Lara Laini (L)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Pierluigi di Mauro (P)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Manuel Zamparini (M)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Vito Amoroso (V)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Alessia Bonalumi (A)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Sara Bosio (S)

SSVD Breast Unit, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Barbara Zanini (B)

Clinical and Experimental Sciences Department, University of Brescia, 25123, Brescia, Italy.

Chiara Buizza (C)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Nicole Villa (N)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Marco Ravanelli (M)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.

Luca Rinaudo (L)

Tecnologie Avanzate SRL, Turin, Italy.

Salvatore Grisanti (S)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Davide Farina (D)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.

Alfredo Berruti (A)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Francesco Donato (F)

Department of Medical and Surgical Specialties Radiological Sciences and Public Health, Unit of Hygiene, Epidemiology, and Public Health, University of Brescia, 25123, Brescia, Italy.

Deborah Cosentini (D)

Medical Oncology Department, ASST Spedali Civili of Brescia, 25123, Brescia, Italy.

Classifications MeSH